Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference [Accessibility Statement] Skip NavigationWASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the 2026 Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026. A corporate presentation is scheduled for 2:15 p.m. Eastern Time.The corporate presentation given at the Citizens Life Sciences Conference may be access ...

are based upon current expectations and assumptions that involve risks, changes in circumstances and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements include, among others, the FDA's ability to complete its review of, and reach a decision with respect to, the imsidolimab BLA by December 12, 2026; Vanda's assumptions regarding how imsidolimab achieves its therapeutic effect; Vanda's ability to obtain FDA approval ...

To add Benzinga News as your preferred source on Google, click here .Here are some other stocks moving in pre-market trading.Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market trading after the company reported the FDA approval of BYSANTI™ (milsaperidone) for the treatment of bipolar I disorder and schizophrenia – a new chemical entity opening new horizons in psychiatric innovation. ...

Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission, which are available at [www.sec.gov].All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this press release is ...